Literature DB >> 28238102

Prevalence of drug interactions in elderly patients with multimorbidity in primary care.

Susana Sánchez-Fidalgo1, Maria Isabel Guzmán-Ramos2, Mercedes Galván-Banqueri2, Máximo Bernabeu-Wittel3, Bernardo Santos-Ramos2.   

Abstract

Background Drug interactions (DIs) are a significant cause of medication-related problems. The aging population, high chronic diseases prevalence and polypharmacy are closely associated factors. Aim of the review To study the prevalence, types and associated factors of DIs in multimorbidity patients of over 65 years of age in primary care. Methods Relevant studies on DI prevalence in this population were reviewed in PubMed, Cochrane Library and EMBASE (January 2000-December 2015). Independent variables (duration, target population, age, sex, mean of drugs and diseases, geographical localization, DI databases used and study designs) and dependent variables (prevalence, number of DIs per 100 patients and per patient, number of clinically-relevant DIs per 100 patients, most common DI and associated factors) were classified for each article. Results The search generated 749 articles and 46 duplicates were discarded. After reviewing, 10 articles were included. Seven studies were observational and 3 were quasi-experimental. Seven out of 10 used interaction databases. Only 2 studies described both actual and potential DIs. The prevalence of multimorbidity patients with DI ranged from 25.1 to 100% and the number of DIs per 100 patients was from 30 to 388.3. All the lower values correspond to the study conducted at the nursing home. This could be due to special care offered in these centres, where the medication is more controlled. The most frequent DIs were reported in five articles. However, these results could not be correlated since they were ranked using different methodologies. ACEIs, diuretics and NSAID were the most common therapeutic groups. Finally, 5 studies identified factors associated with the presence of potential DIs. The number of drugs and age were the most significant factors. Conclusions There is little evidence of prevalence of actual and potential DIs in elderly patients with multimorbidity in outpatient settings, showing widely heterogeneous results.

Entities:  

Keywords:  Aged; Drug interaction; Outpatients; Patients with multimorbidity; Prevalence

Mesh:

Year:  2017        PMID: 28238102     DOI: 10.1007/s11096-017-0439-1

Source DB:  PubMed          Journal:  Int J Clin Pharm


  38 in total

1.  Concordance of severity ratings provided in four drug interaction compendia.

Authors:  Jacob Abarca; Daniel C Malone; Edward P Armstrong; Amy J Grizzle; Philip D Hansten; Robin C Van Bergen; Richard B Lipton
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Mar-Apr

Review 2.  Pharmacokinetics in older persons.

Authors:  Barry J Cusack
Journal:  Am J Geriatr Pharmacother       Date:  2004-12

3.  Health trends in the elderly population: getting better and getting worse.

Authors:  Marti G Parker; Mats Thorslund
Journal:  Gerontologist       Date:  2007-04

Review 4.  [Quality of interaction database management systems].

Authors:  A Rodríguez-Terol; M O Caraballo; D Palma; B Santos-Ramos; T Molina; T Desongles; A Aguilar
Journal:  Farm Hosp       Date:  2009 May-Jun

Review 5.  Polypharmacy-induced drug-drug interactions; threats to patient safety.

Authors:  H Sharifi; M A V Hasanloei; J Mahmoudi
Journal:  Drug Res (Stuttg)       Date:  2014-02-05

6.  Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand.

Authors:  B Janchawee; W Wongpoowarak; T Owatranporn; V Chongsuvivatwong
Journal:  J Clin Pharm Ther       Date:  2005-02       Impact factor: 2.512

7.  Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.

Authors:  J J Gagne; V Maio; C Rabinowitz
Journal:  J Clin Pharm Ther       Date:  2008-04       Impact factor: 2.512

8.  The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register.

Authors:  Kristina Johnell; Inga Klarin
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

9.  Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs.

Authors:  Esther V Uijtendaal; Jeannette E F Zwart-van Rijkom; Wouter W van Solinge; Toine C G Egberts
Journal:  Eur J Clin Pharmacol       Date:  2011-03-19       Impact factor: 2.953

Review 10.  Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review.

Authors:  Dedan Opondo; Saied Eslami; Stefan Visscher; Sophia E de Rooij; Robert Verheij; Joke C Korevaar; Ameen Abu-Hanna
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more
  11 in total

Review 1.  Prevalence of drug interactions in hospitalised elderly patients: a systematic review.

Authors:  Luciana Mello de Oliveira; Juliana do Amaral Carneiro Diel; Alessandra Nunes; Tatiane da Silva Dal Pizzol
Journal:  Eur J Hosp Pharm       Date:  2020-02-10

2.  Drug interactions detected by a computer-assisted prescription system in primary care patients in Spain: MULTIPAP study.

Authors:  Eloísa Rogero-Blanco; Isabel Del-Cura-González; Mercedes Aza-Pascual-Salcedo; Francisca García de Blas González; Carmen Terrón-Rodas; Sergio Chimeno-Sánchez; Eva García-Domingo; Juan A López-Rodríguez
Journal:  Eur J Gen Pract       Date:  2021-12       Impact factor: 1.904

3.  Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.

Authors:  Anna Somogyi-Végh; Zsófia Ludányi; Ábel Erdős; Lajos Botz
Journal:  BMC Pharmacol Toxicol       Date:  2019-05-31       Impact factor: 2.483

4.  Drug-disease interactions in Swedish senior primary care patients were dominated by non-steroid anti-inflammatory drugs and hypertension - a population-based registry study.

Authors:  Katharina Schmidt-Mende; Morten Andersen; Björn Wettermark; Jan Hasselström
Journal:  Scand J Prim Health Care       Date:  2020-07-29       Impact factor: 2.581

5.  Shaping the Future of Digitally Enabled Health and Care.

Authors:  Maureen Spargo; Nicola Goodfellow; Claire Scullin; Sonja Grigoleit; Andreas Andreou; Constandinos X Mavromoustakis; Bárbara Guerra; Marco Manso; Nekane Larburu; Óscar Villacañas; Glenda Fleming; Michael Scott
Journal:  Pharmacy (Basel)       Date:  2021-01-12

6.  Collaborative Medication Reviews to Identify Inappropriate Prescribing in Pre-Admission Medications at Emergency Department Short-Term Ward.

Authors:  Ercan Celikkayalar; Juha Puustinen; Joni Palmgren; Marja Airaksinen
Journal:  Integr Pharm Res Pract       Date:  2021-04-22

7.  Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study.

Authors:  John E Hughes; Veronica Russo; Caroline Walsh; Enrica Menditto; Kathleen Bennett; Caitriona Cahir
Journal:  Drugs Aging       Date:  2021-10-11       Impact factor: 3.923

8.  Prevalence of potentially harmful multidrug interactions on medication lists of elderly ambulatory patients.

Authors:  Tara V Anand; Brendan K Wallace; Herbert S Chase
Journal:  BMC Geriatr       Date:  2021-11-19       Impact factor: 3.921

9.  Drug-drug Interaction-related Uncontrolled Glycemia.

Authors:  Mohamed Anwar Hammad; Balamurugan Tangiisuran; Abeer Mohamed Kharshid; Noorizan Abdul-Aziz; Yahaya Hassan; Nor Azizah Aziz; Tarek Mohamed Elsayed
Journal:  J Pharm Bioallied Sci       Date:  2017 Oct-Dec

10.  Medication-related problems in older people in Catalonia: A real-world data study.

Authors:  Amelia Troncoso-Mariño; Tomás López-Jiménez; Albert Roso-Llorach; Noemí Villén; Ester Amado-Guirado; Marina Guisado-Clavero; Sergio Fernández-Bertolin; Mariona Pons Vigues; Quintí Foguet-Boreu; Concepción Violán
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-11-26       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.